EZH2 and metastatic malignant neoplasm in the lymph nodes: In another study of 46 patients with locoregionally advanced SCCHN, EZH2 protein overexpression was determined as an independent predictor of overall survival and outperformed lymph node metastasis, a known prognostic factor in SCCHN [23].